Introduction
Providing an accurate estimate of the number of children with type 1 diabetes (T1DM) is a vital component of developing health strategies, evaluating the quality of care and driving research. The DiaMond and the Europe and Diabetes study (EURODIAB) and the American Search for Diabetes in Youth study monitored the trends of incidence in different countries through setting-up of population-based regional or national registries. Worldwide data indicate that the incidence of T1D has increased by 2% to 5% worldwide mainly in children and adolescents under the age of 15 years. Genetic, socioeconomic, geographic and environmental factors are thought to contribute to the increased incidence of T1DM. The overall annual increased incidence is estimated to be around 3%. Of the estimated 490,000 children living with T1DM, 24% come from the European Region and 23% from the South-East Asia Region (1) (2) (3) (4) (5) .
Moreover, there is evidence that type 2 diabetes (T2DM) in children and adolescents is increasing in some countries, however reliable data are sparse (1, 2, 6) .
The aim of this study was to determine the incidence and trends of T1DM and T2DM among children and adolescents, aged 6 months-14 years, living in Qatar.
Patients and Methods
This prospective cohort study reports the incidence of new cases of T1DM and T2DM in children and adolescents (aged 6 months -14 years) between January 2012 to December 2016 in Qatar. Identified case subjects during this time were ascertained from two sources and verified using the capture-recapture technique. Data were obtained from the Pediatric Diabetes Center of Hamad Medical Center (HMC), Qatar.
General population data were obtained from the planning and statistics of the Ministry of Development in Qatar (7, 8) .
Trends in incidence were tested with the use of a generalized autoregressive moving average (GARMA) to account for serial correlation (9) .
The study was approved by the Institutional Review Board (IRB) of Hamad Medical Center, Doha (Qatar).
Results
Over study period (2012-2016), 440 children aged 0.5-14 years were diagnosed with type 1 DM and 45 with type 2 DM. The incidence was equal to 28.39/100,000 ( 95% CI of 31.82-40.03), with an increased incidence rate for T1DM of 5.2% compared to the previous years (23.15/100,000) (10), and an annual increased incidence of 1.05 % per year (Table 1 ).
In the same period the incidence of T2DM increased from 1.16 per 100,000 in 2012 to 2.72 per 100,000 in 2016, with a incidence rate for T2DM of 2.9/100,000 per year, and an annual increased incidence of 3.12% (10) .
The age at presentation differed significantly between T1DM and T2DM ( Table 2 ).
Most of T1DM cases occurred in winter and autumn seasons (75%). The male to female ratio in T1DM was 1:1.1 and for T2DM was 1:1.4.
All children and adolescents with T2DM were obese or overweight, and had a positive family history of T2DM.
Discussion
In our study the incidence of T1DM in children and adolescents (0.5-14 years) was considerably high compared to many European countries, and increased from 28.34 per 100,000 in 2012 to 33.2 in 2015 (95% CI of 31.2-40.0). The highest incidence for T1DM in children and adolescents has been reported in Finland (40.9/100,000). Other European countries tend to have lower incidence rates than the Scandinavian countries (United Kingdom 29.8/100,000; Czech Republic 17.2/100,000; Germany 18.3/100,000). Even lower rates have been reported in Slovenia (11.1/100,000), Slovakia (13.6/100,000), and Eastern European countries, such as Greece (9.9/100,000), Croatia (8.9/100,000), Bulgaria (9.4/100,000), Albania (3.9/100,000), Bosnia Herzegovina (3.5/100,000) and Turkey (8.7/100,000 in females and 5.7/100000 in males) (11) (12) (13) (14) (15) (16) (17) (18) (19) (Figure 1 ).
It appears that the incidence of T1DM in children and adolescents living in Qatar is lower compared to Finland and other Scandinavian countries, higher compared to European countries and similar or to some extent lower to the incidence reported from neighbouring countries like Saudi Arabia (Figure 1) , and Kuwait (39.3 /100,000 in boys and 44.1/100000 in girls) (20) (21) (22) . In addition, the incidence in Qatar is higher than the overall estimated incidence reported in the USA (19.5 cases per 100,000, in 2002-2003, and 21.7 cases per 100,000 in 2011-2012) (23). In summary, the incidence rate of T1DM in Qatar is considerably higher compared to other countries all over the world, being the 4th highest rate among 89 countries, published in the International Diabetes Federation's Diabetes Atlas in 2011 (1) (Figure 1) . Furthermore, the incidence of T1DM between 2012-2016 (28.39/100,000) was significantly higher compared to the incidence rate reported between 2006-2011 (23.15/100,000).
Before 2008, there were not registered cases of T2DM in children and adolescents living in Qatar. The reported incidence rate, in children and adolescents, incresead thereafter, from 1.16 per 100,000 in 2012 to 2.72 per 100,000 in 2016, with the inclusive incidence rate of T2DM of 2.75/100,000 per year. This increase is lower compared to USA where the overall unadjusted incidence rates of T2DM increased from 9.0 cases per 100,000 per year in 2002-2003 to 12.5 cases per 100,000 per year in 2011-2012, P<0.001). The high prevalence of obesity and overweight in children and adolescents in Qatar has been found to be strongly correlated with metabolic syndrome and was identified as a risk factor for adverse cardiovascular outcomes in later life (24, 25) .
Conclusions
The incidence rates of both T1DM and T2DM among children and adolescents living in Qatar is considerably higher compared to other countries. A significant trend increase was registered in the 2012-2016 period compared to previous years. Further studies are required to determine the causes of these increases. 
